5Durante Mangoni E, Adinolfi L E, Tripodi M F, et al. Risk factors for " major" embolic events in ho sp italized patients with infective endocarditis[ J]. Am Heart J, 2003, 146 (2) : 311-316.
6Korkmaz S, lleri M, Hisar I, et al. Increased levels of soluble adhesion molecules, E-selection and P-selection, in patients with infective endocarditis and embolic events [ J ]. Eur Heart J, 2001, 22(10) : 874-878.
7Buyukasyk N S, lleri M, Alper A, et al. Increased blood coagulation and platelet activation in paients with infective endocarditis and embolic events [ J ]. Clin Cardiol, 2004, 27 (3) : 154-158.
8Anavekar N S, Tleyieh I M, Anavekar N S, et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis[J]. Clin Infect Dis, 2007, 44 (9) : 1180- 1186.
9Kupferwasser L I, Yeaman M R, Shapiro S M, et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental staphylococcus aureus endocarditis through antiplatelet and antibacterial effects [J]. Circulation, 1999, 99 (21) :2791-2797.
